Elgeka S.A.

Annual / Quarterly Financial Statement • Sep 22, 2015

" ELGEKA S.A. TRADE - DISTRIBUTIONS - REPRESENTATIONS - INDUSTRY "

REG. No 8649/06/Β/86/45

HEAD OFFICE: BLOCK 31, ADRESS: DA 13, PHASE B, 57022, INDUSTRIAL AREA OF SINDOS, DELTA MUNICIPALITY - THESSALONIKI - GREECE SUMMARY FINANCIAL DATA & INFORMATION FOR THE YEAR 1 January 2010 - 31 December 2010 (According to Law 2190, article 135 - for companies which prepare annual financial statements, consolidated and stand alone, in accordance with IFRS

	INFORMATION CONCERNING THE COMPANY
Registered Prefecture:	Ministry of Regional Development and Competitiveness, Director of Societe Anonymes & Credit	Composition of Board of Directors: Chairman & Managing Director (Executive member) Vice-chairman (Executive member)	Alexandros Katsiotis Elli Drakopoulou
Company's website:	http://www.elgeka.gr	Executive members	Vasilios Evgenios
Date of approval of Annual Financial Statements			Anthimos Misailidis
by the Board of Directors:	29 March 2011	Non-executive members	Paraskevas Toktokoglou
Certified Auditor Accountant:	Panagiotis Papazoglou - SOEL Reg. No. 16631		Michail Fandridis
Audit firm:	ERNST & YOUNG (HELLAS) CERTIFIED AUDITORS ACCOUNTANTS S.A.		Stilianos Georgioudakis
Type of auditor's opinion	Unqualified report	Independent, Non-executive members	Kiriakos Sachanidis
			Stilianos Stefanou
	1.1 STATEMENT OF FINANCIAL POSITION (consolidated and stand alone) amounts in thousand Euro	1.4 STATEMENT OF CASH FLOWS (consolidated and stand alone) amounts in thousand Euro
	GROUP COMPANY 31/12/2010 31/12/2009 31/12/2010 31/12/2009	INDIRECT METHOD	GROUP COMPANY 1/1 - 31/12/2010 1/1 - 31/12/2009 1/1 - 31/12/2010 1/1 - 31/12/2009

ASSETS
Tangible assets	56.586	63.791	10.631	10.596	Operating activities
Intangible assets	26.042	17.400	969	1.115	Add/less Adjustments for:
					Results (income, expense, gains & losses)
Other accounts related to Shareholders' Equity	11.981	13.987	10.590	12.785	Add/less adjustments for changes in working capital or
Total Equity attributable to Shareholders of the Parent Company (a)	63.080	65.086	61.689	63.884	changes related to operating activities:
Short-term borrowings	81.295	67.313	26.015	12.307	Less:
TOTAL EQUITY AND LIABILITIES ( c ) + ( d )	332.998	295.253	153.731	142.532	Net cash flows from/(used in)

	31/12/2010	31/12/2009	31/12/2010	31/12/2009	INDIRECT METHOD	1/1 - 31/12/2010	1/1 - 31/12/2009	1/1 - 31/12/2010	1/1 - 31/12/2009
ASSETS
Tangible assets	56.586	63.791	10.631	10.596	Operating activities
Investment property	42.290	44.515	12.856	13.456	Profit / (loss) before taxes (continuing operations)	(416)	(7.169)	(1.508)	1.436
Intangible assets	26.042	17.400	969	1.115	Add/less Adjustments for:
Other non-current assets	20.695	10.984	52.212	37.688	Depreciation and amortization	6.010	6.112	1.223	1.337
Inventories	38.416	34.554	14.095	14.515	Provisions	1.855	2.851	2.501	1.132
Trade receivables	120.221	100.106	51.994	54.740	Unrealised foreign exchange differences	363	1.175	(2)	3
Other assets	28.748	23.903	10.974	10.422	Translation exchanges differences	452	714	0	0
TOTAL ASSETS	332.998	295.253	153.731	142.532	Amortization of government grants	(178)	(219)	0	0
					Results (income, expense, gains & losses)
EQUITY & LIABILITIES					of investing activities	1.173	7.606	775	331
Share capital	51.099	51.099	51.099	51.099	Interest expense & similar charges	5.164	5.556	1.460	1.161
Other accounts related to Shareholders' Equity	11.981	13.987	10.590	12.785	Add/less adjustments for changes in working capital or
Total Equity attributable to Shareholders of the Parent Company (a)	63.080	65.086	61.689	63.884	changes related to operating activities:
Non-controlling interest (b)	10.788	13.273	0	0	Decrease/(increase) in inventories	1.385	1.685	86	2.073
Total Equity ( c ) = ( a ) + ( b )	73.868	78.359	61.689	63.884	Decrease/(increase) in receivables	(13.616)	(3.724)	2.350	(5.220)
Long-term borrowings	19.593	27.978	9.250	11.750	Increase/(decrease) in payables (excluding borrowings)	11.117	4.072	2.337	(1.067)
Provisions / Other long-term liabilities	35.491	34.854	1.320	1.161	Staff leaving indemnities paid	(891)	(904)	(569)	(182)
Short-term borrowings	81.295	67.313	26.015	12.307	Less:
Other current liabilities	122.751	86.749	55.457	53.430	Interest expense & similar charges paid	(4.919)	(5.338)	(1.212)	(1.000)
Total liabilities ( d )	259.130	216.894	92.042	78.648	Income taxes paid	(2.058)	(681)	(784)	(116)
TOTAL EQUITY AND LIABILITIES ( c ) + ( d )	332.998	295.253	153.731	142.532	Net cash flows from/(used in)
					operating activities (a)	5.441	11.736	6.657	(112)
1.2. STATEMENT OF COMPREHENSIVE INCOME (consolidated and stand alone) amounts in thousand Euro
					Investing activities
	GROUP		COMPANY		Share capital increase of subsidiaries	0	0	(1.186)	(1.558)
	1/1 - 31/12/2010	1/1 - 31/12/2009	1/1 - 31/12/2010	1/1 - 31/12/2009	Purchase of available for sale financial assets	(200)	(80)	(200)	(80)
Sales	352.720	317.620	131.123	141.873	Proceeds from sale of available for sale financial assets	5	50	5	50
Gross profit / (loss)	45.009	51.509	26.445	28.533	Acquisition of subsidiaries (less cash and cash equivalents of subsidiaries))	(12.898)	0	(16.655)	0
Profit /(loss) before taxes, financing					Proceeds from sale of subsidiaries (less cash
and investing activities	6.981	7.899	2.452	3.420	and cash equivalents of subsidiaries)	1.777	0	1.800	0
Profit /(loss) before taxes	(416)	(7.169)	(1.508)	1.436	Purchase of property, plant & equipment and intangible assets	(3.982)	(4.500)	(1.147)	(569)
Less: Taxes	1.070	(498)	461	1.022	Proceeds from sale of property, plant & equipment and intangible assets	92	629	36	211
Profit / (loss) after taxes (A)	(1.486)	(6.671)	(1.969)	414	Purchase of investment property	(2)	(79)	0	0
Distributed to:					Proceeds from sale of investment property	730	0	0	0
Equity holders of the Parent	(1.214)	(2.909)	(1.969)	414	Procceds from government grants	984	0	0	0
Non-controlling interest	(272)	(3.762)	0	0	Interest received	195	339	5	3
					Net cash flows from/(used in)
Other comprehensive income/(loss) for the year, net of tax (B)	(885)	(1.455)	(68)	348	investing activities (b)	(13.299)	(3.641)	(17.342)	(1.943)
Total comprehensive income/(loss) for the year, net of tax (A+B)	(2.371)	(8.126)	(2.037)	762
Distributed to:					Financing activities
Equity holders of the Parent	(1.823)	(3.469)	(2.037)	762	Purchase of treasury shares	(158)	0	(158)	0
Non-controlling interest	(548)	(4.657)	0	0	Proceeds from non-controlling interest (due to share
	(2.371)	(8.126)	(2.037)	762	capital increase and establishment of new subsidiaries)	22	5	0	0
					Proceeds from loans	127.672	110.924	19.000	10.068
Profit/(loss) after taxes per share - basic (in Euro)	(0,0381)	(0,0911)	(0,0619)	0,0130	Repayment of loans	(118.099)	(117.928)	(7.900)	(8.069)
Proposed dividend per share (in Euro)	0,0000	0,0000	0,0000	0,0000	Payment of finance leasing liabilities	(1.045)	(985)	0	0
					Net cash flows from/(used in)
Profit /(loss) before taxes, financing, investing					investing activities (c)	8.392	(7.984)	10.942	1.999
activities, depreciation & amortization	12.813	13.795	3.675	4.757	Net increase/(decrease) in cash
					and cash equivalents ( a ) + ( b ) + ( c )	534	111	257	(56)
1.3 STATEMENT OF CHANGES IN EQUITY (consolidated and stand alone) amounts in thousand Euro					Cash and cash equivalents at the beginning of the year	7.871	7.970	130	186
					Foreign exchange differences in cash and cash equivalents	(41)	(210)	0	0
	GROUP		COMPANY		Cash and cash equivalents at the end of the year	8.364	7.871	387	130

	GROUP		COMPANY		Share capital increase of subsidiaries	0	0	(1.186)	(1.558)
	1/1 - 31/12/2010	1/1 - 31/12/2009	1/1 - 31/12/2010	1/1 - 31/12/2009	Purchase of available for sale financial assets	(200)	(80)	(200)	(80)
Sales	352.720	317.620	131.123	141.873	Proceeds from sale of available for sale financial assets	5	50	5	50
Gross profit / (loss)	45.009	51.509	26.445	28.533	Acquisition of subsidiaries (less cash and cash equivalents of subsidiaries))	(12.898)	0	(16.655)	0
Profit /(loss) before taxes, financing					Proceeds from sale of subsidiaries (less cash
and investing activities	6.981	7.899	2.452	3.420	and cash equivalents of subsidiaries)	1.777	0	1.800	0
Profit /(loss) before taxes	(416)	(7.169)	(1.508)	1.436	Purchase of property, plant & equipment and intangible assets	(3.982)	(4.500)	(1.147)	(569)
Less: Taxes	1.070	(498)	461	1.022	Proceeds from sale of property, plant & equipment and intangible assets	92	629	36	211
Profit / (loss) after taxes (A)	(1.486)	(6.671)	(1.969)	414	Purchase of investment property	(2)	(79)	0	0
Distributed to:					Proceeds from sale of investment property	730	0	0	0
Equity holders of the Parent	(1.214)	(2.909)	(1.969)	414	Procceds from government grants	984	0	0	0
Non-controlling interest	(272)	(3.762)	0	0	Interest received	195	339	5	3
					Net cash flows from/(used in)
Other comprehensive income/(loss) for the year, net of tax (B)	(885)	(1.455)	(68)	348	investing activities (b)	(13.299)	(3.641)	(17.342)	(1.943)
Total comprehensive income/(loss) for the year, net of tax (A+B)	(2.371)	(8.126)	(2.037)	762
Distributed to:					Financing activities
Equity holders of the Parent	(1.823)	(3.469)	(2.037)	762	Purchase of treasury shares	(158)	0	(158)	0
Non-controlling interest	(548)	(4.657)	0	0	Proceeds from non-controlling interest (due to share
	(2.371)	(8.126)	(2.037)	762	capital increase and establishment of new subsidiaries)	22	5	0	0
					Proceeds from loans	127.672	110.924	19.000	10.068
Profit/(loss) after taxes per share - basic (in Euro)	(0,0381)	(0,0911)	(0,0619)	0,0130	Repayment of loans	(118.099)	(117.928)	(7.900)	(8.069)
Proposed dividend per share (in Euro)	0,0000	0,0000	0,0000	0,0000	Payment of finance leasing liabilities	(1.045)	(985)	0	0
					Net cash flows from/(used in)
Profit /(loss) before taxes, financing, investing					investing activities (c)	8.392	(7.984)	10.942	1.999
activities, depreciation & amortization	12.813	13.795	3.675	4.757	Net increase/(decrease) in cash
					and cash equivalents ( a ) + ( b ) + ( c )	534	111	257	(56)
1.3 STATEMENT OF CHANGES IN EQUITY (consolidated and stand alone) amounts in thousand Euro					Cash and cash equivalents at the beginning of the year	7.871	7.970	130	186
					Foreign exchange differences in cash and cash equivalents	(41)	(210)	0	0
	GROUP		COMPANY		Cash and cash equivalents at the end of the year	8.364	7.871	387	130

	31/12/2010	31/12/2009	31/12/2010	31/12/2009
Equity at the beginning of the year
(01.01.2010 and 01.01.2009, respectively)	78.359	86.480	63.884	63.122
Total comprehensive income/(loss), net of tax	(2.371)	(8.126)	(2.037)	762
Change in subsidiary ownership due to sale to thirt parties	(1.992)	0	0	0
Purchase of subsidiaries (non-controlling interest proportion)	8	0	0	0
Establishment of subsidiaries (non-controlling interest proportion)	22	0	0	0
Share capital increase of subsidiaries (non-controlling interest proportion)	0	5	0	0
Purchase of treasury shares	(158)	0	(158)	0
Equity at the end of the year (31.12.2010 and 31.12.2009, respectively)	73.868	78.359	61.689	63.884

ADDITIONAL DATA AND INFORMATION

The financial data and information presented below provide a general overview of the financial position and results of the Group and ELGEKA S.A. - Trade - Distributions - Industry. Therefore, it is recommended to any reader, before proceeding to any investment decision or other transaction with the company, to visit the company's website, where the Annual Financial Statements are published, together with the review report of certified auditors - accountants whenever is required.

1. The name and country of registered office for each of the companies included in the consolidated financial statements as per December 31st, 2010, as well as the corresponding direct and indirect percentage of participation in their share capital are included in Note 1 in Consolidated Financial Statements. 2. The accounting principles applied are the same with the ones applied for the preparation of Annual Financial Statements for the year ended on December 31st, 2009, apart from the

new or revised accounting standards and interpretations endorsed in 2010.

3. The Parent Company's tax books and records have been audited by the Tax Authorities up to fiscal year 2006 (incl.). The unaudited fiscal years for each of the companies included into the Consolidated Financial Statements are analytically presented in Note 17 of Annual Financial Statements.

4. There are no encumbrances on the fixed assets of the Parent Company, while there are mortgages on the buildings of subsidiaries as of 31st of December 2010, amounting to Euro 18.939 thousand (31/12/2009: Euro 18.178 thousand) as security for loans.

5. There is no pending litigation that could materially affect the financial position or operation of the Parent Company and the Group. The aggregated amount of provisions for bad and doubtful debts for the Group and Parent Company at 31/12/2010 amounted to Euro 5.414 thousand and Euro 1.306 thousand, respectively. The cumulative provision for tax unaudited years as of 31/12/2010 for the Group amounted to Euro 392 thousand and for the Parent Company to Euro 318 thousand, whereas no provisions were created under the heading "Other Provisions" neither for the Group nor for the Parent Company as prescribed in paragraphs 10, 11 and 14 of IAS 37 "Provision, contingent liabilities and contingent assets". 6. The number of employees as at 31/12/2010 was 1.782 for the Group and 206 for the Parent Company respectively (31/12/2009: Group 1.763 and Company 219, respectively).

7. All activities (sales and purchases of goods and services) aggregating from the beginning of the year as well as receivable and payable balances of the Parent Company and the Group in the end of the current year, created from transactions with related companies, as these are defined in IAS 24, with distinct reference to the remuneration and balances of key management personnel and members of the board, are given below:

c. At 15/04/2010, the Parent Company sold its participation percentage of 30% plus 2 shares to the company "PAPADIMITRIOU S.A." for Euro 1.800 thousand. The participation percentage is currently 19,99% from 50% plus 1 share before the sale. There was no result for the Parent Company as the investment was recorded in cost less any accumulated impairment losses. For the Group, the sale resulted in a profit amounted to Euro 1.008 thousand, that includes the amount of Euro 403 thousand as a gain of valuation at fair value of the remaining participation percentage. The figures of the subsidiary were not material for consolidation purposes. In particular, the sales and the profit (loss) after taxes and noncontrolling interest of the subsidiary at 15/04/2010 that are included in the Consolidated Statement of Comprehensive Income amounted to Euro 1.734 thousand and 128 thousand respectively (31/12/2009: Euro 6.603 thousand and Euro 82 thousand respectively). As a result, the subsidiary company "PAPADIMITRIOU S.A." that was fully consolidated at 31st of December 2009, after the sale at 15/04/2010, is included in Available for Sale Financial Assets at fair value of Euro 1.200 thousand.

a) Sales of goods and services b) Purchases of goods and services c) Receivables d) Payables e) Key management personnel and member of the board compensation f) Receivables from key management personnel and member of the board g) Payables to key management personnel and member of the board Statements as at December 31st, 2010. thousand respectively (2009: Euro 4.579 thousand). 9. Earnings per share (EPS) have been calculated using the weighted average number of ordinary shares in circulation during 2010. "National-P&K Securities A.E.P.E.Y". December 31st 2010. The figures were insignificant for consolidation purposes. PHARMACEUTICAL SOLE LTD "was not included in the Consolidated Financial Statements during the current year, while it was consolidated in the previous year.	GROUP COMPANY - 417 4 4.431 - 129 4 962 1.081 1.077 1 1 4 4 The parent Company's balances of sales-income, purchases-expenses, receivables and payables with related parties have been eliminated for the consolidation of the Financial 8. Investments in fixed assets that took place from the Parent Company and the Group during 2010 amounted to Euro 1.147 thousand (2009: Euro 569 thousand) and Euro 3.984 10. No subsidiary held shares of the Parent Company at the end of the current year. ELGEKA S.A., under the decision of the General Assembly of 30/06/2008 and the Board of Directors Meetings of 21/04/2010, as well as under the decision of the General Assembly of 28/06/2008 and the Board of Directors Meetings of 29/06/2010, and according to the paragraph 16 of the Greek Codified Law 2190/1920, has bought during the year 202.500 treasury shares at the average price of Euro 0,7773 per share, of total value Euro158 thousand, through 11. a. The company "CERA VILLA DESIGN SRL" applied for liquidation to the Romanian Authorities during the first quarter of 2009. The liquidation process is not completed by b. At 16/03/2010 the Group sold its share of interest in "SAMBROOK PHARMA PHARMACEUTICAL SOLE LTD ", whose sole shareholder was the 91,34% subsidiary "SAMBROOK PHARMACEUTICAL S.A.". The sale proceeds amounted to Euro 21 thousand, which represents its share value in the company. The aforementioned sale does not affect the Consolidated Financial Statements, since the figures of the subsidiary are insignificant to the Group (Equity at 31/12/2009 of Euro 70 thousand and losses before tax of Euro 10,6 thousand). From the above sale accrued a profit of Euro 70 thousand for the Group, which is included in "Other Financing Activities Income". Therefore, "SAMBROOK PHARMA	Group's total), to Euro 396 thousand as Profits after taxes and non-controlling interest (-32,62% of Group's total) and to Euro 411 thousand as Equity attributable to the shareholders of the Parent (0,65% of Group's total). Therefore, "DIAKINISIS PORT (CY) LIMITED" included in the Consolidated Financial Statements for the first time during current year, while it was not included the previous year. Apart from the above mentioned changes in the consolidation percentages of the companies' comprising the Group or the non-incorporation of companies that ceased their activities or sold during the current year, there were no alterations in the consolidation methods nor were any companies which were not included in the consolidation as per December 31st, 2010, in comparison with the corresponding year of 2009. The above mentioned events are presented in Note 1 of Annual Financial Statements. 12. The amounts and the nature of the other comprehensive income after taxes are analyzed as follows: Nature of Other Comprehensive Income / (loss) after taxes Valuation of derivatives after taxes Valuation of investment property after taxes Exchange differences from translation of foreign subsidiaries Other comprehensive income / (loss) after taxes 13. The Investment Property of the Group and the Company are stated at fair value by accredited certified valuators. As at December 31s thousand and a loss of Euro 600 thousand, for the Group and the Company respectively, by the investment property valuations. The corresponding amounts for 2009 were a loss of Euro 8.082 thousand and a loss of Euro 285 thousand, for the Group and the Company respectively. 14. Statement of Comprehensive Income of the Group and the Company has been charged by the amount of Euro 71 thousand, which relates to the special contribution for social responsibility of L.3845/2010, as it is referred in Note 17 of Annual Financial Statements. 15. Statement of Comprehensive Income of the Company has been charged by the amount of Euro 1.517 thousand, which relates to impairment loss in the value of participations in subsidiaries "MEDIHELM PHARMAC. WHOLESALE STORE S.A." (impairment loss Euro 1.262 thousand) and "SAMBROOK PHARMACEUTICALS S.A." (impairment loss Euro 255 thousand). The above impairment losses did not affect consolidated Sales, consolidated Profits after taxes and non-controlling interest and consolidated Equity. Details are given in Note 23 of the Annual Financial Statements.	GROUP COMPANY (01.01-31.12.2010) (01.01-31.12.2010) (86) (68) (547) - (252) - (885) (68) , 2010, it was accrued a loss of Euro 2.255
		Thesssaloniki, March 29, 2011
CHAIRMAN OF THE B.o.D. AND MANAGING DIRECTOR	VICE CHAIRMAN OF THE B.o.D.	CHIEF FINANCIAL OFFICER	HEAD OF THE ACCOUNTING DTM
ALEXANDROS KATSIOTIS ID. No. X 232184 / 01	ELLI DRAKOPOULOU ID. No. AΒ 287230 / 06	ANTHIMOS MISAILIDIS ID. No. AΗ 168099 / 08	KONSTANTINOS MEINTANIS ID. No. AΒ 162944 / 06 ACC. REG. No. 0017678 CLASS: A'

d. The Annual General Assembly of "MEDIHELM PHARMAC. WHOLESALE STORE S.A." dated 30/06/2010 decided a share capital decrease of amount of Euro 1.174 thousand with the intention of capitalization of prior years' losses. At the same time, a share capital increase was approved for the amount of Euro 1.186 thousand with the issue of 118.600 new shares with face value Euro 10 each. "ELGEKA S.A." covered the full amount of this share capital increase and at 19/08/2010 paid the amount of Euro 1.186 thousand, resulting in increase of the participation percentage from 96,95% to 98,48% approximately.

e. On July 5th, 2010, the 100% subsidiary company "ELGEKA (CYPRUS) L.T.D." founded a new company named "DIAKINISIS PORT (CY) LIMITED" located in Nicosia of Cyprus. The participation percentage of "ELGEKA (CYPRUS) L.T.D." in the newly founded company "DIAKINISIS PORT (CY) LIMITED", amounted to Euro 40 thousand, is 50,01%. The operations of the new company will be the participation in other companies. Therefore, "DIAKINISIS PORT (CY) LIMITED" included in the Consolidated Financial Statements for the first time during current year, while it was not included the previous year.

f. On July 7th , 2010, the Parent Company acquired a rights option for the purchase of the share capital increase of 99,71% of the shares of the wholesaler "VITA PI S.A." from the listed company "ATLANTIC SUPER MARKET S.A." for the amount of Euro 10.280 thousand. "ELGEKA S.A.", in addition to the resignation from the rights option of the other shareholder to participate in the share capital increase, has paid the total amount of the share capital increase of Euro 1.855 thousand (3.500 thousand shares of Euro 0,53 each) and as a result the participation percentage amounted to 72,92%. In addition, on the same day, the Parent Company purchased the remaining participation percentage by the listed company "ATLANTIC SUPER MARKET S.A." to the wholesaler "VITA PI A.E.B.E" (1.296.182 shares of nominal value of Euro 0,53 each or 27,00% of the share capital) for Euro 4.520 thousand. As a result, the Parent Company's participation percentage has increased to 99,92%."VITA PI S.A." was founded in 1986 and its headquarters are located in Anchialos of Thessaloniki. Its operation is the representation, distribution, and merchandise of food and other consumer products. The contribution of the above company to Group's financial figures at 31/12/20010 amounted to Euro 56.758 thousand as Sales (16,09% of Group's total), to Euro 568 thousand as Profits after taxes and non-controlling interest (-46,79% of Group's total) and to Euro 10.350 thousand as Equity attributable to the shareholders of the Parent (16,41% of Group's total). Therefore, "VITA PI S.A." included in the Consolidated Financial Statements for the first time during current year, while it was not included the previous year.

g. On August 5th , 2010, the newly established subsidiary "DIAKINISIS PORT (CY) LIMITED" founded a new trade limited company named "DIAKINISIS PORT & Co", based in Piraeus. The participation percentage to the newly founded company, amounted to Euro 30 thousand, will be 99%. The objectives of the newly founded company will be the container loading / unloading, storage and other port services. The contribution of the above company to Group's financial figures at 31/12/20010 amounted to Euro 2.340 thousand as Sales (0,66% of Group's total), to Euro 396 thousand as Profits after taxes and non-controlling interest (-32,62% of Group's total) and to Euro 411 thousand as Equity attributable to the shareholders of